Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoidosis.

Ron Margolis1, Careen Y Lowder

  • 1Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

Current Opinion in Ophthalmology
|December 29, 2007
PubMed
Summary
This summary is machine-generated.

Recent research highlights the role of environmental antigens and genetic factors in sarcoidosis pathogenesis. Advances in understanding immune responses may lead to new treatments for this inflammatory disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optic Disc and Macular Edema in a Previously Healthy Teenager.

JAMA ophthalmology·2026
Same author

Impact of Treatment on Inflammatory Choroidal Neovascularization in Patients with Sarcoidosis.

Ocular immunology and inflammation·2026
Same author

Swept-Source OCT and OCT Angiography B-Scan Analysis of Inflammatory Retinal Vascular Changes: Quantitative and Qualitative Assessment.

Ophthalmology. Retina·2026
Same author

The use of Janus kinase inhibitors to treat noninfectious uveitis.

Eye (London, England)·2025
Same author

Semi-Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography in Cataract Surgery Patients.

Ocular immunology and inflammation·2025
Same author

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.

Ocular immunology and inflammation·2025
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Area of Science:

  • Immunology
  • Genetics
  • Epidemiology

Background:

  • Sarcoidosis pathogenesis involves complex interactions between environmental exposures and host genetics.
  • The immune response, including granuloma formation, is central to sarcoidosis development.
  • Genetic factors, particularly human leukocyte antigen genes, influence susceptibility and disease presentation.

Purpose of the Study:

  • To review recent advances in understanding the epidemiologic, immune, and genetic factors in sarcoidosis pathogenesis.
  • To summarize current knowledge on the triggers and cellular mechanisms involved in sarcoidosis.
  • To discuss the implications of new findings for sarcoidosis treatment and management.

Main Methods:

  • Review of recent scientific literature on sarcoidosis.

Related Experiment Videos

  • Analysis of genetic studies, including genome scans and human leukocyte antigen associations.
  • Evaluation of imaging techniques and therapeutic interventions.

    • Main Results:

    • Environmental or occupational antigens are implicated in triggering sarcoidosis in genetically susceptible individuals.
    • Specific human leukocyte antigen genes are associated with sarcoidosis susceptibility and phenotype.
    • High-resolution computed tomography is valuable for diagnosis; novel radionuclide techniques are emerging.
    • Infliximab shows promise for refractory sarcoidosis, while etanercept use is cautioned against.

    Conclusions:

    • Advances in understanding sarcoidosis immunopathogenesis offer potential for improved therapeutic strategies.
    • Targeting immune pathways may reduce both systemic and ocular morbidity associated with sarcoidosis.